GB1312196A - Nicotinic acid derivatives and a process for the manufacture thereof - Google Patents

Nicotinic acid derivatives and a process for the manufacture thereof

Info

Publication number
GB1312196A
GB1312196A GB5436571A GB5436571A GB1312196A GB 1312196 A GB1312196 A GB 1312196A GB 5436571 A GB5436571 A GB 5436571A GB 5436571 A GB5436571 A GB 5436571A GB 1312196 A GB1312196 A GB 1312196A
Authority
GB
United Kingdom
Prior art keywords
nicotinic acid
chloro
hydroxy
base addition
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5436571A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1312196A publication Critical patent/GB1312196A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

1312196 2 - Chloro - 6 - hydroxy - nicotinic acid F HOFFMANN-LA ROCHE & CO AG 23 Nov 1971 [23 Nov 1970 (2)] 54365/71 Heading C2C Novel 2 - chloro - 6 - hydroxy - nicotinic acid and base addition salts thereof are prepared by hydrolysis of 2,6-dichloro-nicotinic acid or a base addition salt thereof, followed by acidification of the hydrolysis product and optional salification of the resulting free acid. Pharmaceutical compositions having hypolipidemic activity comprise, as active ingredient, 2- chloro-6-hydroxy-nicotinic acid or a pharmaceutically acceptable base addition salt thereof, in association with a compatible pharmaceutical carrier, and may be administered orally or parenterally.
GB5436571A 1970-11-23 1971-11-23 Nicotinic acid derivatives and a process for the manufacture thereof Expired GB1312196A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9229570A 1970-11-23 1970-11-23
US9229470A 1970-11-23 1970-11-23

Publications (1)

Publication Number Publication Date
GB1312196A true GB1312196A (en) 1973-04-04

Family

ID=26785491

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5436571A Expired GB1312196A (en) 1970-11-23 1971-11-23 Nicotinic acid derivatives and a process for the manufacture thereof

Country Status (9)

Country Link
AT (1) AT319241B (en)
CH (1) CH557817A (en)
DE (1) DE2157289A1 (en)
ES (1) ES397242A1 (en)
FR (1) FR2115359B1 (en)
GB (1) GB1312196A (en)
IL (1) IL38006A (en)
NL (1) NL7115453A (en)
SE (1) SE371195B (en)

Also Published As

Publication number Publication date
CH557817A (en) 1975-01-15
DE2157289A1 (en) 1972-05-31
ES397242A1 (en) 1975-03-01
AT319241B (en) 1974-12-10
FR2115359B1 (en) 1974-10-18
IL38006A (en) 1974-07-31
FR2115359A1 (en) 1972-07-07
SE371195B (en) 1974-11-11
NL7115453A (en) 1972-05-25
IL38006A0 (en) 1971-12-29

Similar Documents

Publication Publication Date Title
ES460098A1 (en) Derivatives of penicillanic acid
ES419506A1 (en) {8 1-Oxo-2,3-hydrocarbylene-5-indanyloxy(or thio){9 alkanoic acids
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1525640A (en) Apovincaminol derivatives and a process for the preparation thereof
GB1312196A (en) Nicotinic acid derivatives and a process for the manufacture thereof
GB1425150A (en) Therapeutically active phenoxyalkylamines
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1311015A (en) Pharmaceutical compositions and a process for the manufacture thereof
GB1261660A (en) alpha-HYDRAZINO ACIDS
GB1299289A (en) Piperidine derivatives
GB1204809A (en) Novel quinoline derivatives, the preparation thereof and compositions containing the same
GB1263839A (en) A novel aminoethanesulfonic acid
GB1235953A (en) Novel pyridine derivatives, compositions containing the same, and methods of preparing the same
IE33519B1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
GB1437149A (en) Spiro-compounds and a process for their preparation
GB1266430A (en)
GB1169074A (en) Improvements in or relating to Hepato-Protective Drugs
GB1368251A (en) Theophylinylmethylethanoic acid ester
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
GB1380265A (en) Thiazole derivatives
IE38235B1 (en) Preparations for combatting swine dysentery
IE34386L (en) Acetylsalicylic acid-containing composition
GB1247073A (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
GB1317099A (en) 3-sulphamyl-4-chlorobenzoic acid derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees